fashion -WSS

fashion

author：entertainment 2025-10-01 00:17:05 - browse：5217

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： As H5N1 spreads in cows, experts warn against drinking raw milk

WSS

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

ALS treatment from Biogen, Ionis fails in study

Digital health: a case of mistaken identity

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Abbott's new stent may help patients with peripheral artery disease

WuXi Biologics beefs up its lobbying operation

explore

fashion

hotspot

Activists slam private health insurers over coverage restrictions

Scrutiny of post

Medicare proposal to cover medical devices draws a mixed reaction

Addressing health care workers' trauma can help fight burnout

Hepatitis C has a cure — but many Americans still lack access to it

ASCO eve: Let’s set the table for this year's meeting

In age of alternative facts, a scholarly course on calling out crap

H5N1 bird flu outbreak: Second human case reported, in Michigan

Apple is now the first public company to be valued at $3 trillion

CVS is willing to dump 10% of its Medicare Advantage members

explore

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

WuXi Biologics execs register to lobby as Congress comes for the company

Ripples from Flovent's discontinuation is killing children with asthma

Study finds gene variants tied to breast cancer risk in Black women

The White House hikes tariffs on plastic syringes made in China

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

focus

knowledge

knowledge

explore